THERAPEUTIC INTERFERING PARTICLES FOR CORONA VIRUS

SARS-CoV-2 Virus-Like Particles

MODIFIED CORONAVIRUS S PROTEIN

VIRUS-LIKE PARTICLE STABLY EXPRESSED BY ANIMAL CELLS AS VACCINE ANTIGEN AGAINST COVID-19 AND INFLUENZA VIRUS

VACCINE CONSTRUCT AND USES THEREOF

CORONAVIRUS DERIVED RNA REPLICONS AND THEIR USE AS VACCINES

EXOSOME-BASED ANTIVIRAL VACCINE AND MANUFACTURING METHOD THEREOF

MULTIEPITOPE SELF-ASSEMBLED NANOPARTICLE VACCINE PLATFORM (MSN-VACCINE PLATFORM) AND USES THERE OF

Immunomodulatory proteins- or targeting proteins-expressing nanovesicles, methods of preparing the nanovesicle and use thereof

VIRAL-LIKE PARTICLES FOR THE TREATMENT OR PREVENTION OF AN INFECTION BY A CORONAVIRIDAE VIRUS

HIGH-THROUGHPUT SCREENING OF SARS-COV-2 VARIANTS

UTILIZATION OF ANTIBODIES TO SHAPE ANTIBODY RESPONSES TO AN ANTIGEN

Self-Amplifying RNA-Based VLP Vaccines

Peptide VLP-Based Vaccines

EXPRESSION OF SARS-COV PROTEINS, NUCLEIC ACID CONSTRUCTS, VIRUS LIKE PROTEINS (VLPS) AND METHODS RELEVANT THERETO

MODIFIED CORONAVIRUS STRUCTURAL PROTEIN

OPTIMAL PRODUCTION OF SARS-COV-2 VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN MAMMALIAN CELLS

CHIMERIC CORONAVIRUS S PROTEIN COMPOSITIONS AND METHODS OF USE

PARTICLES, DNA & RNA

Modified S1 subunit of the coronavirus spike protein

PANDEMIC-PREPAREDNESS COCKTAIL TO FIGHT CORONAVIRUS OUTBREAKS

METHODS AND COMPOSITIONS OF RNA NANOSTRUCTURES FOR REPLICATION AND SUB-GENOMIC EXPRESSION BY RNA-DIRECTED RNA POLYMERASE

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A SARS-COV-2 INFECTION

CORONAVIRUS VACCINES, COMPOSITIONS, AND METHODS RELATED THERETO

mRNA NANOCAPSULE AND USE IN PREPARATION OF ANTIVIRAL DRUGS

Neutralizing antibody immunoassays

IMMUNOMODULATION PLATFORM AND METHODS OF USE

VIRUS-LIKE PARTICLES

Hybrid alphavirus-SARS-CoV-2 particle and methodology of making and using same

Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine

Virus like nanoparticle compositions and methods thereof

CORONAVIRUS VACCINE AND METHODS OF USE THEREOF

VIRUS LIKE PARTICLE PRODUCTION IN PLANTS

Modified S1 subunit of the coronavirus spike protein

Highly efficient influenza matrix (M1) proteins

Highly efficient influenza matrix (M1) proteins

Oral virus vaccine

Highly efficient influenza matrix (M1) proteins

High-yield transgenic mammalian expression system for generating virus-like particles

Highly efficient influenza matrix (M1) proteins

CHIMERIC VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES

Avian influenza chimeric VLPS

High-yield transgenic mammalian expression system for generating virus-like particles

SARS vaccine

Virus-like particles, methods of preparation, and immunogenic compositions

Expression vector encoding coronavirus-like particle

Corona-virus-like particles comprising functionally deleted genomes

Coronavirus-like particles comprising functionally deleted genomes

SARS-coronavirus virus-like particles and methods of use